ECMO systems market projected to reach 287.6 million dollars by 2020 according to new research report

Extracorporeal membrane oxygenation (ECMO) systems market growing at 4.0% rate and projected to reach 287.6 million dollars by 2020 according to new research report

Global extracorporeal membrane oxygenation (ECMO) system market report purpose is to cover the definition, description, and forecast. It involves deep dive analysis of market segmentation which comprises of submarkets, modality and application.

The report also offers strategic analysis of key players in the market. In this report, the extracorporeal membrane oxygenation (ECMO) system market is segmented on the basis of its modality and application.

In terms of modality, the market is segmented into Veno Arterial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R).

North America contributed to the largest extracorporeal membrane oxygenation (ECMO) system market in 2014.The large share is attributed to rise in the increasing number of patients suffering from respiratory failure and cardiopulmonary disease, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), increasing adoption rate of ECMO machine in hospitals, technological advancements in ECMO system, success rate of ECMO and government initiatives and growing awareness towards ECMO. All these factors would help improve the demand of ECMO machines, which are used on a small scale in hospitals currently.

Complete Report on 78 market data tables & 91 figures spread through 138 pages and in-depth TOC on “Extracorporeal Membrane Oxygenation Systems Market” at .

The global extracorporeal membrane oxygenation (ECMO) system market accounted for USD 227.7 million in 2014 and is expected to reach USD 287.6 million by 2020 at a CAGR of 4.0% from 2015 to 2020.

This market has been segmented by application, which includes Respiratory, Cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR). There spiratory segment was the largest application of the global extracorporeal membrane oxygenation (ECMO) system market in 2014.

Further more, increasing number of patients suffering from respiratory failure and cardiopulmonary disease are other growth factors. With the rising number of cases globally, there is a boost in the growth of extra corporeal membrane oxygenators market.

Respiratory failure may affect the muscles, nerves, bones, or tissues that support breathing, or they may affect the lungs directly. Over 3 million Canadians of all ages have a serious respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), cystic fibrosis, and respiratory distress syndrome.

More than 5 million patients are admitted annually to ICUs in the U.S.

In 2010, cardiovascular, lung, and blood diseases accounted for 1,017,000 deaths and 41 percent of all deaths in the U.S. However, cost of high end equipment, presence of conventional techniques, risk of complications, renal failure associated with ECMO are some of the restraints for the extracorporeal membrane oxygenation (ECMO) system market.

More details on this report at

The report also provides a detailed competitive landscaping of companies operating in this market. It also offers segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of major companies.

The main companies operating in this market are MAQUET Holding B.V. & CO. KG. (Germany), SORIN Group (Italy), MEDTRONIC (Republic of Ireland), NIPRO Medical Corporation (U.S.), Terumo Medical Corporation (Japan), MicroPort Scientific Corporation (China), Medos Medizintechnik AG (Germany).

“Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno -Arterial (VA), Veno -Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography – Global Forecast to 2020” research report can be requested at .

Research report covers basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the Extra corporeal Membrane Oxygenation (ECMO) System market.

News From:

RnR Market Research
Category: Market Research Reports

Company profile: is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.


Recent Blog Posts

Perfusion Services Inc 5000

For the Third Consecutive Year, Keystone Perfusion Services Makes the Inc. 5000 List with Three-Year Revenue Growth of 410 Percent


Fifty Things a Cardiac Surgery Team Can Do for Blood Conservation


ECMO: Last-Resort Life Support Option Helped Majority of Critically Ill COVID-19 Patients Survive, Global Study Shows.


Keystone Perfusion Services, PC Makes Inc. Magazine’s List of 5000 Fastest-Growing Private Companies for Second Time.